Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04930666 · ClinicalTrials.gov registry record
BREATHE ALD: A Shared Decision-Making Intervention for Adults With Advanced Lung Disease
A clinical trial, sponsored by Columbia University.
- Completed
- Registry status
- 30
- Enrollment target
NCT04930666: Completed study, sponsored by Columbia University.
NCT04930666 is a clinical trial that has completed, run by Columbia University. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04930666 has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
This study aims to: 1. Develop the BREATHE-ALD intervention for adults with Advanced Lung Disease, multiple chronic conditions, and palliative care needs and their caregivers using interviews with 10 advanced lung disease (ALD) adults and their caregivers 2. To evaluate the feasibility and acceptability of intervention procedures; and 3. To explore intervention effects on ALD outcomes
Primary Outcome
Qualitative interviews will be conducted with adults with advanced lung disease and their caregivers to understand their experiences managing ALD using semi-structured in-depth individual interviews. The information collected will aid the design of BREATHE-ALD and the implementation of the pilot phase of this study.
Interventions
- OTHER BRief intervention to Enhance Adherence to Treatment and HEalth advice in Advanced Lung Disease
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2021-11-10 |
| Est. Completion | 2025-02-06 |
What the finished NCT04930666 record still lists
NCT04930666 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which BRief intervention to Enhance Adherence to Treatment and HEalth advice in Advanced Lung Disease is the first listed.
NCT04930666 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04930666 about?
NCT04930666 is a clinical study titled "BREATHE ALD: A Shared Decision-Making Intervention for Adults With Advanced Lung Disease". This study aims to: 1. Develop the BREATHE-ALD intervention for adults with Advanced Lung Disease, multiple chronic conditions, and palliative care needs and their caregivers using interviews with 10 advanced lung disease (ALD) adults and their caregivers 2. To evaluate the feasibility and acceptab...
What is the current status of trial NCT04930666?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2021-11-10. Estimated completion is 2025-02-06.
What interventions are being tested in trial NCT04930666?
The interventions under investigation include: BRief intervention to Enhance Adherence to Treatment and HEalth advice in Advanced Lung Disease (OTHER).
Who is sponsoring clinical trial NCT04930666?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI